Zobrazeno 1 - 10
of 108
pro vyhledávání: '"D, Kottaridis"'
Autor:
Ali Alhawaj, Lucia Conde, Panagiotis D Kottaridis, Rosemary E Gale, David L Linch, Marc Mansour
Publikováno v:
HemaSphere, Vol 7, p e57167d3 (2023)
Externí odkaz:
https://doaj.org/article/83163e8da5164413bdeb875f2d59b406
Autor:
James W Day, Thomas A Fox, Rajeev Gupta, Asim Khwaja, Andrew J Wilson, Panagiotis D Kottaridis
Publikováno v:
Leukemia Research Reports, Vol 17, Iss , Pp 100291- (2022)
We report a case of FLT3-mutated AML with t(6;9) in which induction chemotherapy with DA and midostaurin failed to achieve complete cytogenetic or molecular remission. Due to the COVID-19 pandemic and co-existing cellulitis, monotherapy with the sele
Externí odkaz:
https://doaj.org/article/0a2924c4fcdb49bebe7c110679f80e23
Autor:
Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, Nicolaus Kroeger, Mutlu Arat, Keith M. O. Wilson, Jacques-Olivier Bay, Arnold Ganser, Hans Martin, Jakob Passweg, Panagiotis D. Kottaridis, Ibrahim Yakoub-Agha, Rocio Parody Porras, Eva Maria Wagner, Jordi Esteve, Francesco Lanza, Arnon Nagler, Mohamad Mohty
Publikováno v:
Bone Marrow Transplantation. 57:1556-1563
Measurable residual disease (MRD) assessment before allogeneic hematopoietic cell transplantation (HCT) may help physicians to identify a subgroup of patients at high risk of relapse for de novo acute myeloid leukemia (AML) but its relevance among pa
Autor:
Panagiotis D Kottaridis, Janet North, Maria Tsirogianni, Chloe Marden, Edward R Samuel, Sam Jide-Banwo, Sarah Grace, Mark W Lowdell
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0123416 (2015)
Human Natural Killer (NK) cells require at least two signals to trigger tumor cell lysis. Absence of ligands providing either signal 1 or 2 provides NK resistance. We manufactured a lysate of a tumour cell line which provides signal 1 to resting NK c
Externí odkaz:
https://doaj.org/article/0029a4e2241f49f3a21931ea2cce5b92
Autor:
Stephen Mackinnon, Maria del Mar Cuadrado, Alejandro Madrigal, Kirsty Thomson, Jude Dorman, Hanna Renshaw, Stuart J. Ings, Ben Carpenter, Michael J. Watts, Rachael Hough, Ronjon Chakraverty, Emma C. Morris, Mark W. Lowdell, Panagiotis D. Kottaridis, Chloe Anthias, Nishil Patel, Karl S. Peggs, Richard Szydlo
Publikováno v:
Haematologica
Poor graft function is a serious complication following allogeneic hematopoietic stem cell transplantation. Infusion of CD34+-selected stem cells without pre-conditioning has been used to correct poor graft function, but predictors of recovery are un
Autor:
Kirsty Thomson, Panagiotis D. Kottaridis, Fiona Clark, Maryam Subhan, Rajeev Gupta, Naina Chavda, Jenny O'Nions, Adele K. Fielding, Elspeth Payne, Asim Khwaja, Marc R. Mansour, Ethan Troy‐Barnes, Robert Baker, Andrew Wilson
Publikováno v:
British Journal of Haematology
The optimal treatment for patients with newly diagnosed acute myeloid leukaemia (AML) who are infected with severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)/COVID‐19 is unknown.1 We report the case of a previously fit 27‐year‐
Publikováno v:
British Journal of Haematology
As of 17th May, 2020 the number of patients infected by coronavirus disease 2019 (COVID‐19) worldwide has exceeded 4.5 million (WHO 2020). A subgroup of patients with COVID‐19 pneumonia develop a hyperinflammatory syndrome which has a similar cyt
Autor:
Emma C. Morris, Asim Khwaja, Rob S. Sellar, Andrew Grigg, Panagiotis D. Kottaridis, Ben Carpenter, Stephen Mackinnon, Thomas A. Fox, Hugues de Lavallade, Adele K. Fielding, Victoria Potter, Varun Mehra, Karl S. Peggs, Kavita Raj, Antonio Pagliuca, Ronjon Chakraverty, Donal P. McLornan, Ghulam J. Mufti, Austin G. Kulasekararaj, Kirsty Thomson, Anita Sarma
Publikováno v:
British journal of haematology. 187(1)
Autor:
Karl S. Peggs, Shari Denovan, Victoria Grandage, Andrew Symes, Sarah Grace, B Carpenter, Stephen Mackinnon, Ronjon Chakraverty, BJ Uttenthal, Emma C. Morris, Thomas A. Fox, Adele K. Fielding, Rachael Hough, Venetia Bigley, Kirsty Thomson, David M. Lowe, Sarita Workman, Matthew Buckland, Julia Dahlstrom, Panagiotis D. Kottaridis, Siobhan O. Burns
Publikováno v:
Blood. 131(8)
The primary immunodeficiencies (PIDs), rare inherited diseases characterized by severe dysfunction of immunity, have been successfully treated by allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in childhood. Controversy exists regardin
Autor:
Hans J. Stauss, Asim Khwaja, Shao-An Xue, Waseem Qasim, Jacqueline Barry, Emma Nicholson, Michelle Quaye, Stephen D. Robinson, Terri Gaskell, Mandana Ahmadi, Judith King, Francesca Sillito, Nourredine Himoudi, Angelika Holler, Thomas A. Fox, Shannon Inman, Rita Tendeiro-Rego, Ronjon Chakraverty, Kirsty Thomson, Hong Zhan, Panagiotis D. Kottaridis, Emma C. Morris, Natalie Mount, Kurt C. Gunter, Irma Alicia Martínez-Dávila, Andres Virchis, Michaela Sharpe, Sharyn Thomas, Rachel Richardson
Publikováno v:
Blood. 134:1367-1367
Background:Patients with acute myeloid leukemia (AML), myelodysplasia (MDS) or tyrosine kinase inhibitor resistant chronic myeloid leukemia (CML) who are unsuitable for consolidative allogeneic stem cell transplantation (alloSCT) have high relapse ra